Delhi HC Upholds AstraZeneca's Tagrisso Patent, Imposes Rs 7L Fine on 'Habitual Infringer' for Knockoff Production Farhat Nasim2 Dec 2024 4:48 PM ISTNew Delhi: In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical Works Ltd....
27 Formulations Declared Not of Standard Quality, 7 Misbranded: CDSCO Alert Based on State Data Farhat Nasim1 Dec 2024 12:00 PM ISTNew Delhi: The State Drugs Control Laboratories, under the Central Drugs Standard Control Organisation (CDSCO), have issued a detailed alert for...
CDSCO flags PAN-D, TAXIM-O 200, Rosuvas 10 samples as spurious in October 2024 alert Farhat Nasim30 Nov 2024 2:49 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has declared three drugs, Pantoprazole Gastro-resistant and Domeperiodone Prolong...
Cipla slapped with Rs 53L GST penalty for alleged TRAN-1 credit misuse, plans legal challenge Farhat Nasim29 Nov 2024 6:18 PM ISTMumbai: Drug major Cipla Limited has disclosed that the Office of the Principal Commissioner of Central Goods & Services Tax (GST) and Central...
Sun Pharma slapped Rs 76 crore fine by customs authorities Farhat Nasim28 Nov 2024 3:14 PM ISTNew Delhi: Sun Pharmaceutical Industries Limited (Sun Pharma) and its subsidiary, Sun Pharma Laboratories Limited, have been slapped with hefty...
Rising Misinformation But No Action: Govt's Moves On Misleading Health Ads In Limbo Farhat Nasim27 Nov 2024 5:07 PM ISTNew Delhi: The Union Health Ministry, in a response to an RTI dated November 7, disclosed that the proposed amendments to the Drugs and Magic...
Pharmacists Must Now Mandatorily Verify Profiles with ABHA Number: PCI Farhat Nasim26 Nov 2024 5:55 PM ISTNew Delhi: In a move to integrate pharmacists into the Healthcare Professional Registry (HPR) under the Ayushman Bharat Digital Mission (ABDM), the...
NPPA Hikes Price of Cholesterol-Lowering Drug Atorvastatin Farhat Nasim25 Nov 2024 6:23 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently revised the ceiling price of Atorvastatin 10 mg, a widely used...
Abbott's Plea Alleging NPPA Used Outdated PTR Data for Metoprolol Pricing Rejected by DoP Farhat Nasim24 Nov 2024 11:00 AM ISTNew Delhi: A review application filed by Abbott Healthcare, alleging that the National Pharmaceutical Pricing Authority (NPPA) used lower...
DCGI Warns Cosmetic Industry Against Overlapping Claims With Pharma Products Farhat Nasim23 Nov 2024 3:07 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has issued a stern warning to the cosmetics industry to adhere to strict regulatory...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
Setback to Cipla: DoP rejects plea challenging NPPA order for Acivir Tablets pricing Farhat Nasim21 Nov 2024 6:16 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg...
